IRF4 as an Oncogenic Biomarker for Hematological Malignancies

Journal of Oncobiomarkers ◽

10.13188/2325-2340.1000003 ◽

2013 ◽

Vol 1 (1) ◽

Author(s):

Shunbin Ning

Keyword(s):

Hematological Malignancies

Download Full-text

Author response for "Recent advances in chimeric antigen receptor natural killer cell therapy for overcoming intractable hematological malignancies"

10.1002/hon.2802/v2/response1 ◽

2020 ◽

Author(s):

Junji Tanaka

Keyword(s):

Natural Killer Cell ◽

Cell Therapy ◽

Natural Killer ◽

Chimeric Antigen Receptor ◽

Hematological Malignancies ◽

Killer Cell ◽

Antigen Receptor ◽

Author Response ◽

Recent Advances

Download Full-text

Author response for "A pilot assessment of xanthine oxidase activity in plasma from patients with hematological malignancies using a highly‐sensitive assay"

10.1002/hon.2659/v2/response1 ◽

2019 ◽

Author(s):

Noboru Hokama ◽

Takashi Shirakura ◽

Sumito Sunagawa ◽

Satoko Morishima ◽

Sawako Nakachi ◽

...

Keyword(s):

Xanthine Oxidase ◽

Oxidase Activity ◽

Hematological Malignancies ◽

Author Response ◽

Sensitive Assay ◽

Xanthine Oxidase Activity ◽

Highly Sensitive

Download Full-text

Review for "Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies"

10.1002/hon.2759/v1/review1 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Hematological Malignancies ◽

Kidney Injury ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate

Download Full-text

Bifunctional Role of Kruppel-Like Factor 4 in Hematological Malignancies

Forum on Immunopathological Diseases and Therapeutics ◽

10.1615/forumimmundisther.2016017234 ◽

2016 ◽

Vol 7 (1-2) ◽

pp. 141-151

Author(s):

Mario Morales-Martinez ◽

Luz A. Franco-Cea ◽

Liliana Moreno Vargas ◽

Otoniel Martinez-Maza ◽

Sara Huerta-Yepez ◽

...

Keyword(s):

Hematological Malignancies

Download Full-text

Detection of Bloodstream Pathogens in Hematological Malignancies

Case Medical Research ◽

10.31525/ct1-nct03896880 ◽

2019 ◽

Author(s):

Keyword(s):

Hematological Malignancies

Download Full-text

Dual PD-1 and JAK2 Inhibition in Hematological Malignancies

Case Medical Research ◽

10.31525/ct1-nct04016116 ◽

2019 ◽

Author(s):

Keyword(s):

Hematological Malignancies ◽

Jak2 Inhibition

Download Full-text

Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies

Case Medical Research ◽

10.31525/ct1-nct04290000 ◽

2020 ◽

Author(s):

Keyword(s):

T Cells ◽

Biological Samples ◽

Hematological Malignancies ◽

Car T Cells ◽

Download Full-text

Faculty Opinions recommendation of Targeting HIF1α eliminates cancer stem cells in hematological malignancies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11822959.12920055 ◽

2011 ◽

Author(s):

Juan Carlos Zúñiga-Pflücker ◽

Patricia Benveniste

Keyword(s):

Cancer Stem Cells ◽

Hematological Malignancies

Download Full-text

Faculty Opinions recommendation of Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30522.487876 ◽

2006 ◽

Author(s):

Ben de Pauw

Keyword(s):

Hematological Malignancies ◽

Antifungal Prophylaxis ◽

Clinical Issues

Download Full-text

Faculty Opinions recommendation of Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718001876.793475255 ◽

2013 ◽

Author(s):

Livio Pagano ◽

Morena Caira

Keyword(s):

Treatment Outcome ◽

Hematological Malignancies ◽

Fungal Infections ◽

Invasive Fungal Infections

Download Full-text